You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

First-line Platinum-Based Chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gynecologic Cancer Trial (Experimental product - Fortifit® Powder, Standard of care)

Not yet recruiting
  • Gynecologic Cancer
  • Experimental product - Fortifit® Powder
  • Standard of care
  • (no location specified)
Oct 14, 2023

Metastatic Squamous NSCLC Trial in Großhansdorf (Pembrolizumab, Placebo)

Terminated
  • Metastatic Squamous Non-small Cell Lung Cancer
  • Großhansdorf, Germany
    LungenClinic Grosshansdorf
Dec 14, 2021

Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Bern, Switzerland
    University Hospital Insel
Feb 20, 2023

Cervical Cancer Trial in Chongqing, Fuzhou (TQB2868 injection, Paclitaxel injection, Cisplatin injection)

Not yet recruiting
  • Cervical Cancer
  • TQB2868 injection
  • +4 more
  • Chongqing, Chongqing, China
  • +1 more
Aug 17, 2023

NSCLC (NSCLC) Trial (Ociperlimab, Placebo, Tislelizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • (no location specified)
Mar 17, 2023

NSCLC Stage IV Trial in Gauting (combination regimen tremelimumab /durvalumab, platinum-based chemo (SoC))

Withdrawn
  • NSCLC Stage IV
  • combination regimen tremelimumab /durvalumab
  • platinum-based chemotherapy (SoC)
  • Gauting, Germany
    Asklepios Fachkliniken München-Gauting
Sep 26, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Beijing (Fluzoparib; Apatinib, Fluzoparib, Placebo)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • Fluzoparib; Apatinib
  • +2 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Apr 22, 2022

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

Patients With Stage IV or Recurrent Adenocarcinoma of the Lung Trial (Abraxane, Gemcitabine)

Completed
Has Results
  • Patients With Stage IV or Recurrent Adenocarcinoma of the Lung
  • (no location specified)
Sep 28, 2021

Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Dendritic cell vaccination
  • +2 more
  • Edegem, Antwerp, Belgium
  • +2 more
Feb 28, 2023

Toripalimab, First-line Treatment Trial in Guangzhou (EP/EC+PD-1)

Recruiting
  • Toripalimab
  • First-line Treatment
  • Guangzhou, Guangdong, China
    Sun Yat-sen University cancer center
Mar 7, 2023

Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

Not yet recruiting
  • Cervical Cancer
  • Recombinant humanized anti-PD-1 monoclonal antibody injection
  • +4 more
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Nov 3, 2023

NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 17, 2023

SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)

Not yet recruiting
  • SCLC,Extensive Stage
  • AK104 IV infusion；Chiauranib oral
  • Changchun, Jilin, China
    Jilin Province Cancer Hospital
Aug 16, 2022

Ovarian Cancer Trial (Fluzoparib, QL1101)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Oct 18, 2022

Non Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib and Platinum)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • IBI-322 Plus Lenvatinib and Platinum
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 14, 2022

Urothelial Carcinoma Trial in Italy (Niraparib, Best supportive care)

Completed
  • Urothelial Carcinoma
  • Alba, Italy
  • +19 more
May 16, 2022

Advanced Non-squamous Non-Small-Cell Lung Cancer Trial in Jinan (Sintilimab)

Recruiting
  • Advanced Non-squamous Non-Small-Cell Lung Cancer
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Dec 4, 2022

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Non-Small-Cell Lung Cancer Trial in Jinan (Recombinant human endostatin (Endostar))

Recruiting
  • Non-Small-Cell Lung Cancer
  • Recombinant human endostatin (Endostar)
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Oct 8, 2022

Squamous NSCLC, Non-Squamous NSCLC Trial (Durvalumab, Tremelimumab)

Withdrawn
  • Squamous Non-small Cell Lung Cancer
  • Non-Squamous Non-small Cell Lung Cancer
  • (no location specified)
Dec 17, 2021

NSCLC Trial in Saint Petersburg, Cremona, Vilnius (REGN2810/ipi, REGN2810/chemo/ipi, Pembrolizumab)

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Saint Petersburg, Florida
  • +2 more
Oct 22, 2022

Cervical Cancer Trial (BAVC-C+Durvalumab)

Not yet recruiting
  • Cervical Cancer
  • BAVC-C+Durvalumab
  • (no location specified)
Mar 14, 2021

Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib)

Not yet recruiting
  • Small Cell Lung Cancer
  • IBI-322 Plus Lenvatinib
  • Changsha, Hunan, China
    Hunan Cancer hospital
Jul 14, 2022

Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)

Completed
  • Urothelial Carcinoma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 22, 2021